Will Cannabis Seeds

Will Cannabis Genetics Be Restricted?

A redefinition of hemp under federal law, set to take place Nov. 12, signals the end of Farm Bill protections for numerous hemp-derived THC products across the country: low-dose beverages as well as THCA bud and delta-8 THC edibles, vapes and additional products sold at gas stations and smoke shops.

But the hemp ban also generates a significant complication for the legal cannabis sector. Seeds from cannabis cultivars that produce flower with greater than 0.3% THC are no longer legal to transport out of state.

Although seed purchases will likely continue in legal states, the changes threaten to shutter some seed suppliers and genetics businesses, observers say, while creating supply-chain problems for cannabis growers and retailers.

“If this wording goes through, we will need pop-up stores to offer seeds in each state where it’s permitted,” Campanella said. “Which is why we’re also providing clones and tissue cultivation, because that’s not covered in the bill.”

When are cannabis genetics and clones prohibited to ship between state lines?

The new regulations classify seeds based on the THC capacity of the parent plant. Genetic substances such as seeds and clones are rendered illegal if the end product crosses the threshold.

For the moment, seeds are currently shipping under the 2018 Farm Bill’s current quo. But the clock is ticking for enterprises like Brothers Grimm and for cannabis growers who worry about supply chain interruptions if out-of-state availability to genetics is banned.

Most of the cannabis industry remains mostly unaware of the approaching shutdown of the interstate genetics marketplace, said Ryan Power, cofounder of Sebastopol, California-based company Atlas Seed.

Without federal intervention in the form of a carve-out for seeds or an overall moratorium, many seed providers will simply be shuttered come November, he added.

“We are functioning legally now, but if that changes, it will disrupt the legal licensed sector in every state,” said Power, whose clientele includes seed suppliers as well as licensed business cultivators.

“Consumers are going to lose choice, and it will be a significant shutdown for most people.”

What are cannabis seed banks doing to remain legal after the government hemp ban?

Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics company, because of state Senate Bill 56, which tightened cannabis supervision in that state while also restricting hemp-derived THC products to licensed cannabis retailers.

Previously a seed supplier, Silberhaze is currently focused on the branding, preservation and IP protection of elite plant genetics.

That’s because seed businesses hoping to stay compliant in this updated environment must have airtight documentation, https://nativesusa.com/; nativesusa.com, he said.

“You have to prove where this stuff comes from, so it’s extremely important to have documentation, even to the point where you have cultivator names,” Silber said.

“Small businesses will have to work with improved records and a stronger chain of custody,” he added. “We need that documentation ourselves, because we don’t want to be dealing with questionable sources.”

To prevent seizures and other legal consequences, seed entrepreneurs must “get their ducks in a row” before the new regulations take effect, Silber said.

“Review all your materials immediately, and categorize what you can,” Silber said. “Take stock, document your heritage, preserve breeder records, and arrange any cannabinoid or terpene information you already have. If regulations shift, you’ll be in a far better position to comprehend what may be impacted and make educated decisions.”

Does government marijuana rescheduling affect cannabis genetics?

Silber believes U.S. Drug Enforcement Administration registration may be necessary for companies engaged in research.

But for now, seed companies can’t register with the DEA like state-licensed therapeutic cannabis operators can. Such an option is unavailable to seed suppliers, nurseries or genetics businesses, said Jim Ickes, a lawyer and partner with Frantz Ward’s cannabis law group in Cleveland.

“Genetics activity may be occurring inside larger state-licensed therapeutic marijuana businesses, as some states permit dispensaries or registered medical operators to sell seeds, clones or personal growing materials,” he said.

“But that is distinct from the DEA creating a freestanding seed bank registration category.”

Some genetics companies are already changing operational practices to conform with the updated law. According to Ickes, they must answer questions including:

• Which of our lines produce plants over 0.3% total THC?
• Which seeds remain as hemp after Nov. 12, 2026, and which don’t?
• What does our inventory look like once we sort it against the viable-seed exclusion?

Ickes also recognizes confusion from customers who believed federal rescheduling of therapeutic marijuana would resolve their story with banking institutions. However, the latest regulatory wording has moved those conversations beyond the basics of classification, he said.

“Banks ask whether this specific revenue source is lawful, whether it ties to state-licensed operations, or whether there’s interstate-commerce risk,” said Ickes.

“After November, a seed supplier selling high-THC genetics can’t address the first question with the hemp classification. It has to refer to a lawful state cannabis pathway instead. Seed banks dealing in genuine industrial-hemp seed keep the cleaner story.”

What’s the outlook of cannabis genetics?

Campanella is a member of a emerging coalition of fellow breeders, growers and researchers that’s arguing seeds are better defined as farm inputs than regulated substances. To that end, seeds should be managed by the U.S. Department of Agriculture, allowing the DEA to focus its enforcement work elsewhere.

“How do you control something based on what it might become later?” said Campanella. “Our choice is to have that language removed, or have seeds regulated by the USDA as a hemp product.”

But in the interim, Campanella is restructuring Brothers Grimm to operate outside the scope of shifting federal oversight. The company plans to keep its Colorado seed operation while positioning its Oklahoma tissue cultivation facility as a hedge against federal prohibition of cannabis seeds.

As she noted: “If things evolve in a way where we can’t concentrate on interstate transport, we’ll have other resources to satisfy people’s requirements without getting ourselves in trouble.”